| - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite S | Phase II | rekrutiert |
| 177Lu-DOTATATE for Recurrent Meningioma | Phase II | rekrutiert |
| A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lastin | Phase II | rekrutiert |
| A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis | Phase I | rekrutiert |
| A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK- | Phase III | rekrutiert |
| A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melano | Phase II | rekrutiert |
| A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID- | Phase III | rekrutiert |
| A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorub | Phase II | rekrutiert |
| A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients | Phase III | rekrutiert |
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity | Phase III | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Co | Phase II / Phase III | rekrutiert |
| A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Mi | Phase III | rekrutiert |
| A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic M | Phase III | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of | Phase II | rekrutiert |
| A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patien | Phase III | rekrutiert |
| A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in | Phase I / Phase II | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis | Phase III | rekrutiert |
| A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic L | Phase III | rekrutiert |
| A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: D | — | rekrutiert |
| A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on | Phase II | rekrutiert |
| A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tube | — | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, Prospective Study With Benralizumab | — | rekrutiert |
| A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy | Phase I / Phase II | rekrutiert |
| A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia | Phase I | rekrutiert |
| A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Diseas | Phase II | rekrutiert |
| A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOV | Phase II | rekrutiert |
| A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermati | Phase II | rekrutiert |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With | Phase III | rekrutiert |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Inv | Phase III | rekrutiert |
| A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo | Phase III | rekrutiert |
| A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Synd | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Pl | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo i | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo i | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and | Phase III | rekrutiert |
| A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab P | Phase I | rekrutiert |
| A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan | Phase III | rekrutiert |
| A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study | — | rekrutiert |
| A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) | Phase III | rekrutiert |
| A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propi | Phase III | rekrutiert |
| A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglob | — | rekrutiert |
| A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in Pe | Phase II | rekrutiert |
| A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function | Phase II | rekrutiert |
| A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A | Phase III | rekrutiert |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart | Phase III | rekrutiert |
| A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carbopla | Phase III | rekrutiert |
| A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa | Phase II / Phase III | rekrutiert |
| A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH | Phase III | rekrutiert |
| A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NAS | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosi | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Ref | Phase II | rekrutiert |
| A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Do | Phase III | rekrutiert |
| A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune | Phase III | rekrutiert |
| A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Ce | Phase III | rekrutiert |
| A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Her | — | rekrutiert |
| A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With | — | rekrutiert |
| A Study With CIT-013 in HS Patients | Phase II | rekrutiert |
| A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Ch | Phase III | rekrutiert |
| A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With | Phase III | rekrutiert |
| A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First | Phase III | rekrutiert |
| A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in P | Phase III | rekrutiert |
| A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian C | Phase III | rekrutiert |
| A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic | Phase III | rekrutiert |
| A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With | Phase I / Phase II | rekrutiert |
| A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced So | Phase I / Phase II | rekrutiert |
| A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Al | Phase III | rekrutiert |
| A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagn | Phase III | rekrutiert |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early | Phase III | rekrutiert |
| A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulce | Phase II | rekrutiert |
| A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors | Phase II | rekrutiert |
| A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapse | Phase III | rekrutiert |
| A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal S | Phase III | rekrutiert |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) | Phase II | rekrutiert |
| A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With | Phase I / Phase II | rekrutiert |
| A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated | Phase II / Phase III | rekrutiert |
| A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors | Phase I | rekrutiert |
| A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers | Phase I | rekrutiert |
| A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps | Phase III | rekrutiert |
| A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Co | Phase II | rekrutiert |
| A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic No | Phase II | rekrutiert |
| A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring | Phase I / Phase II | rekrutiert |
| A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cance | Phase III | rekrutiert |
| A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or L | Phase II | rekrutiert |
| A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tra | Phase III | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease | Phase III | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Canc | Phase III | rekrutiert |
| A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRI | Phase II | rekrutiert |
| A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Particip | Phase II | rekrutiert |
| A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult an | Phase III | rekrutiert |
| A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Trea | — | rekrutiert |
| A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa | Phase II | rekrutiert |
| A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis | Phase II | rekrutiert |
| A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF | Phase II | rekrutiert |
| A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart ( | Phase III | rekrutiert |
| A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Aga | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combi | Phase III | rekrutiert |
| A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chro | Phase II | rekrutiert |
| A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Mo | Phase II | rekrutiert |
| A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-M | Phase III | rekrutiert |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients W | Phase II | rekrutiert |
| A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migrai | Phase II | rekrutiert |
| A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participan | Phase I / Phase II | rekrutiert |
| A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEP | Phase III | rekrutiert |
| A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants Wi | Phase III | rekrutiert |
| A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard | Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cir | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Co | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Y | Phase II | rekrutiert |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants | Phase II | rekrutiert |
| A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilim | Phase I / Phase II | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis | Phase II | rekrutiert |
| A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontro | Phase III | rekrutiert |
| A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Veneto | Phase III | rekrutiert |
| A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose | Phase IV | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Grave | Phase II | rekrutiert |
| A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis i | Phase II | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Pl | Phase III | rekrutiert |
| A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in A | Phase III | rekrutiert |
| A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sep | Phase II | rekrutiert |
| A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Th | Phase I / Phase II | rekrutiert |
| A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Particip | Phase II | rekrutiert |
| A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients Wit | Phase III | rekrutiert |
| A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis | — | rekrutiert |
| A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Neph | Phase III | rekrutiert |
| A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult | Phase III | rekrutiert |
| A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standar | Phase III | rekrutiert |
| A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 | Phase II | rekrutiert |
| A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in t | Phase I | rekrutiert |
| A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Fa | Phase III | rekrutiert |
| A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of | Phase III | rekrutiert |
| A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in P | Phase I / Phase II | rekrutiert |
| A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and | — | rekrutiert |
| A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis De | Phase III | rekrutiert |
| A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD | Phase II | rekrutiert |
| A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma | Phase II / Phase III | rekrutiert |
| A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rit | Phase III | rekrutiert |
| A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Ri | Phase III | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Sol | Phase II | rekrutiert |
| AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia | Phase I / Phase II | rekrutiert |
| AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platin | Phase III | rekrutiert |
| Abbott Vascular Medical Device Registry | — | rekrutiert |
| Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At | Phase II | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| Affera Global Registry | — | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Trea | Phase III | rekrutiert |
| An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psor | — | rekrutiert |
| An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) | Phase II | rekrutiert |
| An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defects | — | rekrutiert |
| An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patie | — | rekrutiert |
| An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical | — | rekrutiert |
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-ter | Phase III | rekrutiert |
| An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in | Phase III | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Phase III | rekrutiert |
| Asciminib Roll-over Study | Phase IV | rekrutiert |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipopr | Phase III | rekrutiert |
| Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer | Phase II | rekrutiert |
| Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected St | Phase III | rekrutiert |
| BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT | ohne Phasenangabe | rekrutiert |
| Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa | Phase II | rekrutiert |
| CAR-T Long Term Follow Up (LTFU) Study | Phase III | rekrutiert |
| CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry | — | rekrutiert |
| CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitu | Phase III | rekrutiert |
| Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello- | Phase III | rekrutiert |
| Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer | Phase II | rekrutiert |
| Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Ad | Phase III | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation | Phase II | rekrutiert |
| Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients | Phase III | rekrutiert |
| Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and | Phase I | rekrutiert |
| Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations | Phase II | rekrutiert |
| Clinical Value and Cost-effectiveness of a Personalized Prevention Program (PPP) in Patients Wit | ohne Phasenangabe | rekrutiert |
| Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Loca | Phase IV | rekrutiert |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute My | Phase I / Phase II | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparing a Suture-based System for the Removal of Arterial and Veinous ECMO Cannulas to the Sta | ohne Phasenangabe | rekrutiert |
| Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck | ohne Phasenangabe | rekrutiert |
| Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracra | ohne Phasenangabe | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women | ohne Phasenangabe | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration | ohne Phasenangabe | rekrutiert |
| Cyclosporine In Takotsubo Syndrome | Phase II | rekrutiert |
| DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig P | Phase III | rekrutiert |
| DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis | ohne Phasenangabe | rekrutiert |
| DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device | — | rekrutiert |
| De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcino | ohne Phasenangabe | rekrutiert |
| Depemokimab Asthma Imaging and Bronchoscopy Sub-Study | Phase III | rekrutiert |
| Dexamethasone Eluting Cochlear Implant: a Pivotal Study | ohne Phasenangabe | rekrutiert |
| Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis | Phase II | rekrutiert |
| Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling | ohne Phasenangabe | rekrutiert |
| Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma | Phase II | rekrutiert |
| Dynamic Network Response to TMS Treatment | — | rekrutiert |
| Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab | — | rekrutiert |
| Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigatio | ohne Phasenangabe | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Phase III | rekrutiert |
| EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in N | Phase III | rekrutiert |
| Early Catheter-directed Treatment of High Risk Pulmonary Embolism | ohne Phasenangabe | rekrutiert |
| Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function | ohne Phasenangabe | rekrutiert |
| Effects of Frontopolar TMS in Alcohol Craving | ohne Phasenangabe | rekrutiert |
| Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease | Phase II | rekrutiert |
| Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients W | Phase II / Phase III | rekrutiert |
| Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chron | Phase III | rekrutiert |
| Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged | Phase III | rekrutiert |
| Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therap | Phase III | rekrutiert |
| Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally | — | rekrutiert |
| Electroporation Treatment for Early AF Management in Heart Failure With Preserved Ejection Fract | ohne Phasenangabe | rekrutiert |
| Endometrial Cancer Lymphadenectomy Trial | ohne Phasenangabe | rekrutiert |
| Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial | ohne Phasenangabe | rekrutiert |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With | Phase II | rekrutiert |
| Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With | Phase III | rekrutiert |
| Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia | Phase III | rekrutiert |
| Expected and Actual Preterm-Birth and Parental Distress: Impact on Children's Mental Health | — | rekrutiert |
| Fosfomycin I.v. for Treatment of Severely Infected Patients | — | rekrutiert |
| Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor | Phase II | rekrutiert |
| GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological | — | rekrutiert |
| GISAR German Interdisciplinary Sarcoma Registry | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| German Cardiac Arrest Registry | — | rekrutiert |
| German Pediatric Hemophilia Research Database | — | rekrutiert |
| Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment | — | rekrutiert |
| Global Registry and Natural History Study for Mitochondrial Disorders | — | rekrutiert |
| HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory | Phase I / Phase II | rekrutiert |
| HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediat | Phase I / Phase II | rekrutiert |
| HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pedi | Phase I / Phase II | rekrutiert |
| HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT) | Phase III | rekrutiert |
| Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III) | ohne Phasenangabe | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL | Phase III | rekrutiert |
| IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION | — | rekrutiert |